Remepy
Pioneering Hybrid Drugs
Active
Seed
Startup
Ramat Gan
Founded 2021-12
Remepy is pioneering hybrid drugs, and redefining combination therapy. Its mission is to bring better personalized care to patients. Remepy’s Digital molecules are mobile applications designed for hybrid drug experiences, each containing a unique digital treatment protocol. Its Digital molecules include digitized, standardized, evidence-based interventions,…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$25.0M
Employees59
Founded2021-12
HQRamat Gan
Patents1
Confidence89
Sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals